We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Common Anti-fungal Drug Considered for Use in Cystic Fibrosis

News   Mar 13, 2019 | by Molly Campbell, Science Writer, Technology Networks

 
Common Anti-fungal Drug Considered for Use in Cystic Fibrosis

In people with cystic fibrosis, a protein that releases bicarbonate, a key infection-fighting agent (represented by red spheres), is missing or defective (brown ribbon structure). The drug amphotericin (white structure) can form channels to release bicarbonate in lung tissue. Credit: Rebecca Schultz, Carle Illinois College of Medicine

 
 
Advertisement
 

RELATED ARTICLES

Pilot Study Suggests the Feasibility of Convalescent Plasma Therapy for COVID-19

News

A pilot study suggests the feasibility of convalescent plasma (CP) therapy for treating COVID-19 patients. No specific antiviral treatments exist for SARS-CoV-2, the virus that causes COVID-19, creating a need for alternative treatment strategies.

READ MORE

A Cheaper Way To Study the Immune System, One Cell at a Time

News

Scientists describe a more efficient way to sequence individual cells and visualize the massive amount of data that ensues.

READ MORE

What Cells Does SARS-CoV-2 Attack?

News

Researchers in Germany have examined samples from non-virus infected patients and determined that the receptor for SARS-CoV-2 is primarily expressed in certain progenitor cells in the bronchi.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science Diagnostics Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE